Delivery Order SPE2DR25D1205-SPE2DR26F1BF9
Award Date 2/5/26
Potential Completion Date 2/6/26
Potential Value $59K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $19,277.63. This is a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's capability to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.88 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 162 mg/0.9 ml syringes. This is a firm fixed price delivery order with a completion date of September 2, 2025, with no set-aside designation applied. The contract represents a competitive award under DLA's broader pharmaceutical supply framework, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,303.85 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation and represents a single-line pharmaceutical delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $16,453.58. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and no set-aside designation was used in the award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes, with a contract ceiling value of $27,883.43. The order was competitively awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order utilizes firm fixed-price pricing and carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.88 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 162 mg/0.9 mL syringes. The contract reflects a firm fixed price arrangement with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, consistent with the vendor's track...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Actemra 80 mg/4 mL vials, with a ceiling value of $1,924.58 and an ultimate completion date of December 16, 2025. This non-set-aside, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- On January 2, 2026, the Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes valued at $12,275.06, with an ultimate completion date of January 5, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $16,194.07 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 ml syringes on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is listed as Conshohocken, PA. This delivery order is issued under...
- This delivery order, awarded on January 7, 2026, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), covers the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $1,501.48 and an ultimate completion date of January 8, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...